Proofs of the structure of lipid coated nanoparticles (SMBV™) used as drug carriers

被引:61
作者
De Miguel, I [1 ]
Imbertie, L [1 ]
Rieumajou, V [1 ]
Major, M [1 ]
Kravtzoff, R [1 ]
Betbeder, D [1 ]
机构
[1] Biovector Therapeut SA, F-31676 Labege, France
关键词
supramolecular biovector; liposome; characterisation; zeta potential; fluorescence; microscopy;
D O I
10.1023/A:1007504124603
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Supramolecular Biovectors (SMBV(TM)) consist of cross-linked cationic nanoparticles surrounded by a lipid membrane. The purpose was to study the structure of the lipid membrane and to characterise its interaction with the nanoparticles in order to differentiate SMBV(TM) from other polymer/lipid associations. Methods. The interaction of lipids with the nanoparticle surface was studied using zeta potential, Fluorescence Energy Transfer (FET) and Fluorescence Microscopy. SMBV(TM) were compared to liposomes and mixtures nanoparticles/liposomes. Finally the structure of SMBV(TM) was visualised by Electron Microscopy. Results. Zeta potential measurements showed that lipids on SMBV(TM) had a pronounced shielding effect on the surface charge. This was not the case for mixtures of nanoparticles and liposomes. FET experiments confirmed these results indicating that, for SMBV(TM), the lipids are much closer to the nanoparticle surface. SMBV(TM) Fluorescence microscopy on model microparticles showed a lipid crown on SMBV(TM) that was confirmed by electron microscopy on SMBV(TM) nanoparticles. Conclusions. Results show that in case of SMBV(TM) lipids are strongly adsorbed on the polysaccharide core surface probably due to ionic/hydrophobic interactions. The resulting supramolecular structure is a spherical cationic polysaccharide particle surrounded by a phospholipid/cholesterol layer.
引用
收藏
页码:817 / 824
页数:8
相关论文
共 26 条
[1]   SupraMolecular BioVectors (SMBV) improve antisense inhibition of erbB-2 expression [J].
Allal, C ;
Sixou, S ;
Kravtzoff, R ;
Soulet, N ;
Soula, G ;
Favre, G .
BRITISH JOURNAL OF CANCER, 1998, 77 (09) :1448-1453
[2]  
Barratt G, 1999, PHARM TECH EUR, V11, P25
[3]   Improved oligonucleotide uptake and stability by a new drug carrier, the SupraMolecular BioVector (SMBV) [J].
Berton, M ;
Sixou, S ;
Kravtzoff, R ;
Dartigues, C ;
Imbertie, L ;
Allal, C ;
Favre, G .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1997, 1355 (01) :7-19
[4]  
BETBEDER D, 1998, Patent No. 9829557
[5]  
BETBEDER D, Patent No. 9606638
[6]  
BETBEDER D, 1998, Patent No. 9829099
[7]   STABILIZATION AND ENHANCEMENT OF INTERLEUKIN-2 IN-VITRO BIOACTIVITY BY NEW CARRIERS - SUPRAMOLECULAR BIOVECTORS [J].
CASTIGNOLLES, N ;
BETBEDER, D ;
IOUALALEN, K ;
MERTEN, O ;
LECLERC, C ;
SAMAIN, D ;
PERRIN, P .
VACCINE, 1994, 12 (15) :1413-1418
[8]   A new family of carriers (biovectors) enhances the immunogenicity of rabies antigens [J].
Castignolles, N ;
Morgeaux, S ;
GontierJallet, C ;
Samain, D ;
Betbeder, D ;
Perrin, P .
VACCINE, 1996, 14 (14) :1353-1360
[9]   SYNTHESIS AND CHARACTERIZATION OF SUPRAMOLECULAR BIOVECTOR (SMBV) SPECIFICALLY DESIGNED FOR THE ENTRAPMENT OF IONIC MOLECULES [J].
DEMIGUEL, I ;
IOUALALEN, K ;
BONNEFOUS, M ;
PEYROT, M ;
NGUYEN, F ;
CERVILLA, M ;
SOULET, N ;
DIRSON, R ;
RIEUMAJOU, V ;
IMBERTIE, L ;
SOLERS, C ;
CAZES, S ;
FAVRE, G ;
SAMAIN, D .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1237 (01) :49-58
[10]   SURFACE DENSITY DETERMINATION IN MEMBRANES BY FLUORESCENCE ENERGY-TRANSFER [J].
FUNG, BKK ;
STRYER, L .
BIOCHEMISTRY, 1978, 17 (24) :5241-5248